MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
51.18
-2.08 (-3.91%)
At close: Sep 17, 2025, 4:00 PM EDT
52.00
+0.82 (1.60%)
Pre-market: Sep 18, 2025, 8:30 AM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $3.25 billion as of September 18, 2025. Its market cap has increased by 8.84% in one year.
Market Cap
3.25B
Enterprise Value
2.90B
1-Year Change
8.84%
Ranking
Category
Stock Price
$51.18
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.25B, an increase of 90,226.03%. That is a compound annual growth rate of 566.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.38B | -0.96% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |